BACKGROUND: Guidelines to provide recommendations about driving restrictions for patients with brain metastases are lacking. We aim to determine whether clinical neurologic examination is sufficient to predict suitability to drive in these patients by comparison with an occupational therapy driving assessment (OTDA). METHODS: We prospectively evaluated the concordance between neurology assessment of suitability to drive (pass/fail) and OTDA in 41 individuals with brain metastases. Neuro-oncology evaluation included an interview and neurological examination. Participants subsequently underwent OTDA during which a battery of objective measures of visual, cognitive, and motor skills related to driving was administered. RESULTS: The mean age of patients who failed OTDA was age 68.9 years vs 59.3 years in the group members who passed (P = .0046). The sensitivity of the neurology assessment to predict driving fitness compared with OTDA was 16.1% and the specificity 90%. The 31 patients who failed OTDA were more likely to fail Vision Coach, Montreal Cognitive Assessment, and Trail Making B tests. CONCLUSIONS: There was poor association between the assessment of suitability to drive by neurologists and the outcome of the OTDA in patients with brain metastases. Subtle deficits that may impair the ability to drive safely may not be evident on neurologic examination. The positive predictive value was high to predict OTDA failure. Age could be a factor affecting OTDA performance. The results raise questions about the choice of assessments in making recommendations about driving fitness in people with brain metastases. OTDA should be strongly considered in patients with brain metastases who wish to continue driving.
BACKGROUND: Guidelines to provide recommendations about driving restrictions for patients with brain metastases are lacking. We aim to determine whether clinical neurologic examination is sufficient to predict suitability to drive in these patients by comparison with an occupational therapy driving assessment (OTDA). METHODS: We prospectively evaluated the concordance between neurology assessment of suitability to drive (pass/fail) and OTDA in 41 individuals with brain metastases. Neuro-oncology evaluation included an interview and neurological examination. Participants subsequently underwent OTDA during which a battery of objective measures of visual, cognitive, and motor skills related to driving was administered. RESULTS: The mean age of patients who failed OTDA was age 68.9 years vs 59.3 years in the group members who passed (P = .0046). The sensitivity of the neurology assessment to predict driving fitness compared with OTDA was 16.1% and the specificity 90%. The 31 patients who failed OTDA were more likely to fail Vision Coach, Montreal Cognitive Assessment, and Trail Making B tests. CONCLUSIONS: There was poor association between the assessment of suitability to drive by neurologists and the outcome of the OTDA in patients with brain metastases. Subtle deficits that may impair the ability to drive safely may not be evident on neurologic examination. The positive predictive value was high to predict OTDA failure. Age could be a factor affecting OTDA performance. The results raise questions about the choice of assessments in making recommendations about driving fitness in people with brain metastases. OTDA should be strongly considered in patients with brain metastases who wish to continue driving.
Authors: Johnell Brooks; Julia Seeanner; Sarah Hennessy; Joseph Manganelli; Matthew Crisler; Patrick Rosopa; Casey Jenkins; Michael Anderson; Nathalie Drouin; Leah Belle; Constance Truesdail; Stephanie Tanner Journal: Am J Occup Ther Date: 2017 Mar/Apr
Authors: Barbara Freund; Stefan Gravenstein; Rebecca Ferris; Bonnie L Burke; Elias Shaheen Journal: J Gen Intern Med Date: 2005-03 Impact factor: 5.128
Authors: Susan G R McDuff; Zachary J Taich; Joshua D Lawson; Parag Sanghvi; Eric T Wong; Fred G Barker; Fred H Hochberg; Jay S Loeffler; Peter C Warnke; Kevin T Murphy; Arno J Mundt; Bob S Carter; Carrie R McDonald; Clark C Chen Journal: J Neurol Neurosurg Psychiatry Date: 2013-05-28 Impact factor: 10.154
Authors: Adam Gerstenecker; Louis B Nabors; Karen Meneses; John B Fiveash; Daniel C Marson; Gary Cutter; Roy C Martin; Christina A Meyers; Kristen L Triebel Journal: J Neurooncol Date: 2014-07-18 Impact factor: 4.130
Authors: Christina A Meyers; Jennifer A Smith; Andrea Bezjak; Minesh P Mehta; James Liebmann; Tim Illidge; Ian Kunkler; Jean-Michel Caudrelier; Peter D Eisenberg; Jacobus Meerwaldt; Ross Siemers; Christian Carrie; Laurie E Gaspar; Walter Curran; See-Chun Phan; Richard A Miller; Markus F Renschler Journal: J Clin Oncol Date: 2004-01-01 Impact factor: 44.544
Authors: George D Papandonatos; Brian R Ott; Jennifer D Davis; Peggy P Barco; David B Carr Journal: J Am Geriatr Soc Date: 2015-10-27 Impact factor: 5.562
Authors: Matthew Chan; David Ferguson; Elaine Ni Mhurchu; Ren Yuan; Lovedeep Gondara; Michael McKenzie; Robert Olson; Brian Thiessen; Nafisha Lalani; Roy Ma; Alan Nichol Journal: Radiat Oncol Date: 2020-11-25 Impact factor: 3.481